|
1
|
Matsushima H, Goto T, Hosaka Y, Kitamura T
and Kawabe K: Correlation between proliferation, apoptosis and
angiogenesis in prostate carcinoma and their relation to androgen
ablation. Cancer. 85:1822–1827. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Visakorpi T, Kallioniemi O-P, Koivula T
and Isola J: New prognostic factors in prostatic carcinoma. Eur
Urol. 24:438–449. 1993.PubMed/NCBI
|
|
3
|
Weidner N, Carroll PR, Flax J, Blumenfeld
W and Folkman J: Tumor angiogenesis correlates with metastasis in
invasive prostate carcinoma. Am J Pathol. 143:401–409.
1993.PubMed/NCBI
|
|
4
|
Egelbald M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar
|
|
5
|
Ray JM and Stetler-Stevenson WG: The role
of matrix metalloproteinases and their inhibitors in tumor
invasion, metastasis and angiogenesis. Eur Respir J. 7:2062–2072.
1994.PubMed/NCBI
|
|
6
|
Miyata Y, Iwata T, Ohba K, Kanda S,
Nishikido M, Koga S and Kanetake H: Expression of matrix
metalloproteinase-7 on cancer cells and tissue endothelial cells in
renal cell carcinoma: prognostic implication and clinical
significance for invasion and metastasis. Clin Cancer Res.
15:6998–7003. 2006. View Article : Google Scholar
|
|
7
|
Wood M, Fudge K, Mohler AR, Frost AR,
Garcia F, Wang M and Stearns ME: In situ hybridization studies of
metalloproteinase 2 and 9 and TIMP-1 and TIMP-2 expression in human
prostate cancer. Clin Exp Metastasis. 15:246–258. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pavlaki M and Zucker S: Matrix
metalloproteinase inhibitors (MMPIs): the beginning of the phase I
or the termination of phase III clinical trials. Cancer Metastasis
Rev. 22:177–203. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Arlt M, Kopitz C, Pennington KL, Watson
KL, Krell HW, Bode W, Gansbacher B, Khokha R, Edward DR and Krüger
A: Increase in gelatinase-specificity of matrix metalloproteinase
inhibitors correlated with antimetastatic efficacy in a T-cell
lymphoma model. Cancer Res. 62:5543–5550. 2002.PubMed/NCBI
|
|
10
|
Miyazaki K, Koshikawa N, Hasegawa S,
Momiyama N, Nagashima Y, Moriyama K, Ichikawa Y, Ishikawa T,
Mitsuhashi M and Shimada H: Matrilysin as target for chemotherapy
for colon cancer: use of antisense oligonucleotides as
antimetastatic agents. Cancer Chemother Pharmacol. 43:S52–S55.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mathew R, Khanna R, Kumar R, Mathur M,
Shukla NK and Ralhan R: Stromelysis-2 overexpression in human
esophageal squamous cell carcinoma: potential clinical
implications. Cancer Detect Prev. 26:222–228. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Miyata Y, Iwata T, Maruta S, Kanda S,
Nishikido M and Kanetake H: Expression of matrix
metalloproteinase-10 in renal cell carcinoma. Eur Urol. 52:791–797.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Meyer E, Vollmer J-Y, Bovey R and
Stamenkovic I: Matrix metalloproteinase 9 and 10 inhibit protein
kinase C-potentiated, p-53-mediated apoptosis. Cancer Res.
65:4261–4272. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Miyata Y, Koga S, Kanda S, Nishikido M,
Hayashi T and Kanetake H: Expression of cyclooxygenase-2 in renal
cell carcinoma: correlation with tumor cell proliferation,
apoptosis, angiogenesis, expression of matrix metalloproteinase-2
and survival. Clin Cancer Res. 9:1741–1749. 2003.
|
|
15
|
Bai M, Agnantis N, Kamina S, Demou A,
Zagorianakou P, Katsaraki A and Kanavaros P: In vivo cell kinetics
in breast carcinogenesis. Breast Cancer Res. 3:276–283. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Singh S, Singh UP, Grizzle WE and Lillard
JW Jr: CXCL12-CXCR4 interactions modulate prostate cancer cell
migration, metalloproteinase expression and invasion. Lab Invest.
84:1666–1676. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Singh S, Singh UP, Stiles JK and Lillard
JW Jr: Expression and functional role of CCR9 in prostate cancer
cell migration and invasion. Clin Cancer Res. 10:8743–8750. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Adachi Y, Yamamoto H, Itoh F, Arimura Y,
Nishi M, Endo T and Imai K: Clinicopathologic and prognostic
significance of matrilysin expression at the invasive front in
human colorectal cancers. Int J Cancer. 95:290–294. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gu ZD, Li JY, Li M, Gu J, Shi XT, Ke Y and
Chen KY: Matrix metalloproteinase expression correlates with
survival in patients with esophageal squamous cell carcinoma. Am J
Gastroenterol. 100:1835–1843. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Navarrete MA, Maier CM, Falzoni R, Gerk de
Azevedo Quadros L, Kima GR, Baracat EC and Nazário AC: Assessment
of the proliferative, apoptotic and cellular renovation indices of
the human mammary epithelium during the follicular and luteal
phases of the menstrual cycle. Breast Cancer Res. 7:R306–R313.
2005. View
Article : Google Scholar
|
